Disc Medicine reports Phase 2 DISC-3405 data from RESTORE-PV
Disc Medicine said initial Phase 2 RESTORE-PV data showed DISC-3405 controlled hematocrit and markedly reduced phlebotomy events.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.